193 related articles for article (PubMed ID: 31340035)
1. Nanobody stability engineering by employing the ΔTm shift; a comparison with apparent rate constants of heat-induced aggregation.
Kunz P; Ortale A; Mücke N; Zinner K; Hoheisel JD
Protein Eng Des Sel; 2019 Dec; 32(5):241-249. PubMed ID: 31340035
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Aggregation Propensity of Single-Domain Antibodies upon Heat-Denaturation Employing the ΔT
Kunz P
Methods Mol Biol; 2022; 2446():233-244. PubMed ID: 35157276
[TBL] [Abstract][Full Text] [Related]
3. The structural basis of nanobody unfolding reversibility and thermoresistance.
Kunz P; Zinner K; Mücke N; Bartoschik T; Muyldermans S; Hoheisel JD
Sci Rep; 2018 May; 8(1):7934. PubMed ID: 29784954
[TBL] [Abstract][Full Text] [Related]
4. Exploiting sequence and stability information for directing nanobody stability engineering.
Kunz P; Flock T; Soler N; Zaiss M; Vincke C; Sterckx Y; Kastelic D; Muyldermans S; Hoheisel JD
Biochim Biophys Acta Gen Subj; 2017 Sep; 1861(9):2196-2205. PubMed ID: 28642127
[TBL] [Abstract][Full Text] [Related]
5. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
6. Positive charge in the complementarity-determining regions of synthetic nanobody prevents aggregation.
Zhong Z; Yang Y; Chen X; Han Z; Zhou J; Li B; He X
Biochem Biophys Res Commun; 2021 Oct; 572():1-6. PubMed ID: 34332323
[TBL] [Abstract][Full Text] [Related]
7. The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies.
Akazawa-Ogawa Y; Uegaki K; Hagihara Y
J Biochem; 2016 Jan; 159(1):111-21. PubMed ID: 26289739
[TBL] [Abstract][Full Text] [Related]
8. Direct Immobilization of Engineered Nanobodies on Gold Sensors.
Simões B; Guedens WJ; Keene C; Kubiak-Ossowska K; Mulheran P; Kotowska AM; Scurr DJ; Alexander MR; Broisat A; Johnson S; Muyldermans S; Devoogdt N; Adriaensens P; Mendes PM
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17353-17360. PubMed ID: 33845569
[TBL] [Abstract][Full Text] [Related]
9. Role of a noncanonical disulfide bond in the stability, affinity, and flexibility of a VHH specific for the Listeria virulence factor InlB.
Mendoza MN; Jian M; King MT; Brooks CL
Protein Sci; 2020 Apr; 29(4):1004-1017. PubMed ID: 31981247
[TBL] [Abstract][Full Text] [Related]
10. Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications.
Akazawa-Ogawa Y; Takashima M; Lee YH; Ikegami T; Goto Y; Uegaki K; Hagihara Y
J Biol Chem; 2014 May; 289(22):15666-79. PubMed ID: 24739391
[TBL] [Abstract][Full Text] [Related]
11. An integrated computational pipeline for designing high-affinity nanobodies with expanded genetic codes.
Padhi AK; Kumar A; Haruna KI; Sato H; Tamura H; Nagatoishi S; Tsumoto K; Yamaguchi A; Iraha F; Takahashi M; Sakamoto K; Zhang KYJ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415295
[TBL] [Abstract][Full Text] [Related]
12. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
13. Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes.
Fridy PC; Thompson MK; Ketaren NE; Rout MP
Anal Biochem; 2015 May; 477():92-4. PubMed ID: 25707320
[TBL] [Abstract][Full Text] [Related]
14. Structure and specificity of several triclocarban-binding single domain camelid antibody fragments.
Tabares-da Rosa S; Wogulis LA; Wogulis MD; González-Sapienza G; Wilson DK
J Mol Recognit; 2019 Jan; 32(1):e2755. PubMed ID: 30033524
[TBL] [Abstract][Full Text] [Related]
15. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
Pain C; Dumont J; Dumoulin M
Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
[TBL] [Abstract][Full Text] [Related]
16. Applications of nanobodies in plant science and biotechnology.
Wang W; Yuan J; Jiang C
Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
[TBL] [Abstract][Full Text] [Related]
17. Characterization of single-domain antibodies with an engineered disulfide bond.
Hussack G; Mackenzie CR; Tanha J
Methods Mol Biol; 2012; 911():417-29. PubMed ID: 22886266
[TBL] [Abstract][Full Text] [Related]
18. Solubility and stability engineering of human VH domains.
Kim DY; Ding W; Tanha J
Methods Mol Biol; 2012; 911():355-72. PubMed ID: 22886262
[TBL] [Abstract][Full Text] [Related]
19. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.
Vincke C; Loris R; Saerens D; Martinez-Rodriguez S; Muyldermans S; Conrath K
J Biol Chem; 2009 Jan; 284(5):3273-3284. PubMed ID: 19010777
[TBL] [Abstract][Full Text] [Related]
20. Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension.
Fan K; Jiang B; Guan Z; He J; Yang D; Xie N; Nie G; Xie C; Yan X
Anal Chem; 2018 May; 90(9):5671-5677. PubMed ID: 29634235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
